Literature DB >> 15452150

The role of hypoxia inducible factor 1 (HIF-1) in hypoxia induced apoptosis.

A E Greijer1, E van der Wall.   

Abstract

Apoptosis can be induced in response to hypoxia. The severity of hypoxia determines whether cells become apoptotic or adapt to hypoxia and survive. A hypoxic environment devoid of nutrients prevents the cell undergoing energy dependent apoptosis and cells become necrotic. Apoptosis regulatory proteins are delicately balanced. In solid tumours, hypoxia is a common phenomenon. Cells adapt to this environmental stress, so that after repeated periods of hypoxia, selection for resistance to hypoxia induced apoptosis occurs. These resistant tumours probably have a more aggressive phenotype and may have decreased responsiveness to treatment. The key regulator of this process, hypoxia inducible factor 1 (HIF-1), can initiate apoptosis by inducing high concentrations of proapoptotic proteins, such as BNIP3, and can cause stabilisation of p53. However, during hypoxia, antiapoptotic proteins, such as IAP-2, can be induced, whereas the proapoptotic protein Bax can be downregulated. During hypoxia, an intricate balance exists between factors that induce or counteract apoptosis, or even stimulate proliferation. Understanding the regulation of apoptosis during hypoxia and the mechanisms of resistance to apoptosis might lead to more specific treatments for solid tumours.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15452150      PMCID: PMC1770458          DOI: 10.1136/jcp.2003.015032

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  81 in total

1.  The von Hippel-Lindau gene product inhibits renal cell apoptosis via Bcl-2-dependent pathways.

Authors:  P Devarajan; M De Leon; F Talasazan; A R Schoenfeld; E J Davidowitz; R D Burk
Journal:  J Biol Chem       Date:  2001-08-20       Impact factor: 5.157

2.  Adenovirus E1B 19 kDa and Bcl-2 proteins interact with a common set of cellular proteins.

Authors: 
Journal:  Cell       Date:  1994-12-16       Impact factor: 41.582

3.  Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation.

Authors:  P Jaakkola; D R Mole; Y M Tian; M I Wilson; J Gielbert; S J Gaskell; A von Kriegsheim; H F Hebestreit; M Mukherji; C J Schofield; P H Maxwell; C W Pugh; P J Ratcliffe
Journal:  Science       Date:  2001-04-05       Impact factor: 47.728

4.  A new role for hypoxia in tumor progression: induction of fragile site triggering genomic rearrangements and formation of complex DMs and HSRs.

Authors:  A Coquelle; F Toledo; S Stern; A Bieth; M Debatisse
Journal:  Mol Cell       Date:  1998-08       Impact factor: 17.970

5.  BNIP3 and genetic control of necrosis-like cell death through the mitochondrial permeability transition pore.

Authors:  C Vande Velde; J Cizeau; D Dubik; J Alimonti; T Brown; S Israels; R Hakem; A H Greenberg
Journal:  Mol Cell Biol       Date:  2000-08       Impact factor: 4.272

6.  Apoptosis in hypoxic human pancreatic islets correlates with HIF-1alpha expression.

Authors:  Wolfgang Moritz; Franziska Meier; Deborah M Stroka; Mauro Giuliani; Patrick Kugelmeier; Philipp C Nett; Roger Lehmann; Daniel Candinas; Max Gassmann; Markus Weber
Journal:  FASEB J       Date:  2002-03-26       Impact factor: 5.191

7.  Direct interactions between HIF-1 alpha and Mdm2 modulate p53 function.

Authors:  Delin Chen; Muyang Li; Jianyuan Luo; Wei Gu
Journal:  J Biol Chem       Date:  2003-02-26       Impact factor: 5.157

8.  BNIP3 plays a role in hypoxic cell death in human epithelial cells that is inhibited by growth factors EGF and IGF.

Authors:  Shilpa Kothari; Jeannick Cizeau; Eileen McMillan-Ward; Sara J Israels; Michelle Bailes; Karen Ens; Lorrie A Kirshenbaum; Spencer B Gibson
Journal:  Oncogene       Date:  2003-07-24       Impact factor: 9.867

9.  Dominant-negative hypoxia-inducible factor-1 alpha reduces tumorigenicity of pancreatic cancer cells through the suppression of glucose metabolism.

Authors:  Jian Chen; Songji Zhao; Kunihiro Nakada; Yuji Kuge; Nagara Tamaki; Futoshi Okada; Jingxin Wang; Masanobu Shindo; Fumihiro Higashino; Kohji Takeda; Masahiro Asaka; Hiroyuki Katoh; Toshio Sugiyama; Masuo Hosokawa; Masanobu Kobayashi
Journal:  Am J Pathol       Date:  2003-04       Impact factor: 4.307

10.  Relation of hypoxia inducible factor 1 alpha and 2 alpha in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival.

Authors:  A Giatromanolaki; M I Koukourakis; E Sivridis; H Turley; K Talks; F Pezzella; K C Gatter; A L Harris
Journal:  Br J Cancer       Date:  2001-09-14       Impact factor: 7.640

View more
  223 in total

1.  Different susceptibility of rat pancreatic alpha and beta cells to hypoxia.

Authors:  Konstantin Bloch; Julia Vennäng; Daniel Lazard; Pnina Vardi
Journal:  Histochem Cell Biol       Date:  2012-02-05       Impact factor: 4.304

2.  Hypoxia modulates EWS-FLI1 transcriptional signature and enhances the malignant properties of Ewing's sarcoma cells in vitro.

Authors:  Dave N T Aryee; Stephan Niedan; Maximilian Kauer; Raphaela Schwentner; Idriss M Bennani-Baiti; Jozef Ban; Karin Muehlbacher; Michael Kreppel; Robert L Walker; Paul Meltzer; Christopher Poremba; Reinhard Kofler; Heinrich Kovar
Journal:  Cancer Res       Date:  2010-05-04       Impact factor: 12.701

3.  The tumour suppressor C/EBPδ inhibits FBXW7 expression and promotes mammary tumour metastasis.

Authors:  Kuppusamy Balamurugan; Ju-Ming Wang; Hsin-Hwa Tsai; Shikha Sharan; Miriam Anver; Robert Leighty; Esta Sterneck
Journal:  EMBO J       Date:  2010-11-12       Impact factor: 11.598

Review 4.  Role of CYP2E1 in Mitochondrial Dysfunction and Hepatic Injury by Alcohol and Non-Alcoholic Substances.

Authors:  Mohamed A Abdelmegeed; Seung-Kwon Ha; Youngshim Choi; Mohammed Akbar; Byoung-Joon Song
Journal:  Curr Mol Pharmacol       Date:  2017       Impact factor: 3.339

5.  Basal HIF-1α expression levels are not predictive for radiosensitivity of human cancer cell lines.

Authors:  D Schilling; C Bayer; K Emmerich; M Molls; P Vaupel; R M Huber; G Multhoff
Journal:  Strahlenther Onkol       Date:  2012-02-10       Impact factor: 3.621

Review 6.  Chronic renal ischemia in humans: can cell therapy repair the kidney in occlusive renovascular disease?

Authors:  Ahmed Saad; Sandra M Herrmann; Stephen C Textor
Journal:  Physiology (Bethesda)       Date:  2015-05

7.  Hepatotoxic interaction of sulindac with lipopolysaccharide: role of the hemostatic system.

Authors:  Wei Zou; Sachin S Devi; Erica Sparkenbaugh; Husam S Younis; Robert A Roth; Patricia E Ganey
Journal:  Toxicol Sci       Date:  2008-12-12       Impact factor: 4.849

8.  Knockdown of Hypoxia-Inducible Factor 1α Improved the Efficacy of Low-Dose Metronomic Chemotherapy of Paclitaxel in Human Colon Cancer Xenografts.

Authors:  Mu Zhang; Chen Chen; Feng Su; Zhiguo Huang; Xiangmin Li; Xiaogang Li
Journal:  Technol Cancer Res Treat       Date:  2016-08-29

9.  Regulation of HIF-1alpha and VEGF by miR-20b tunes tumor cells to adapt to the alteration of oxygen concentration.

Authors:  Zhang Lei; Bo Li; Zhuoshun Yang; Haoshu Fang; Gui-Mei Zhang; Zuo-Hua Feng; Bo Huang
Journal:  PLoS One       Date:  2009-10-29       Impact factor: 3.240

10.  FEM-based oxygen consumption and cell viability models for avascular pancreatic islets.

Authors:  Peter Buchwald
Journal:  Theor Biol Med Model       Date:  2009-04-16       Impact factor: 2.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.